HRMY logo

HRMY Cash From Operations

Annual CFO:

$219.82M+$434.00K(+0.20%)
December 31, 2024

Summary

  • As of today, HRMY annual cash from operations is $219.82 million, with the most recent change of +$434.00 thousand (+0.20%) on December 31, 2024.
  • During the last 3 years, HRMY annual cash from operations has risen by +$121.26 million (+123.04%).
  • HRMY annual cash from operations is now at all-time high.

Performance

HRMY Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYcash flow metrics

Quarterly CFO:

$108.73M+$29.41M(+37.07%)
September 30, 2025

Summary

  • As of today, HRMY quarterly cash from operations is $108.73 million, with the most recent change of +$29.41 million (+37.07%) on September 30, 2025.
  • Over the past year, HRMY quarterly cash from operations has increased by +$38.23 million (+54.23%).
  • HRMY quarterly cash from operations is now at all-time high.

Performance

HRMY Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYcash flow metrics

TTM CFO:

$297.61M+$38.23M(+14.74%)
September 30, 2025

Summary

  • As of today, HRMY TTM cash from operations is $297.61 million, with the most recent change of +$38.23 million (+14.74%) on September 30, 2025.
  • Over the past year, HRMY TTM cash from operations has increased by +$76.69 million (+34.71%).
  • HRMY TTM cash from operations is now at all-time high.

Performance

HRMY TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

HRMY Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+0.2%+54.2%+34.7%
3Y3 Years+123.0%+97.0%+91.6%
5Y5 Years+391.4%+1130.3%+2383.7%

HRMY Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+123.0%at high+307.6%at high+106.0%
5Y5-Yearat high+391.4%at high+1130.3%at high+2383.7%
All-TimeAll-Timeat high+391.4%at high+507.2%at high+774.8%

HRMY Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$108.73M(+37.1%)
$297.61M(+14.7%)
Jun 2025
-
$79.33M(+133.4%)
$259.38M(+16.5%)
Mar 2025
-
$33.99M(-55.0%)
$222.67M(+1.3%)
Dec 2024
$219.82M(+0.2%)
$75.56M(+7.2%)
$219.82M(-0.5%)
Sep 2024
-
$70.50M(+65.4%)
$220.92M(+3.5%)
Jun 2024
-
$42.62M(+36.9%)
$213.52M(+2.7%)
Mar 2024
-
$31.14M(-59.4%)
$207.97M(-5.2%)
Dec 2023
$219.39M(+51.9%)
$76.67M(+21.5%)
$219.39M(+29.5%)
Sep 2023
-
$63.10M(+70.3%)
$169.40M(+4.9%)
Jun 2023
-
$37.06M(-12.9%)
$161.50M(+2.1%)
Mar 2023
-
$42.56M(+59.5%)
$158.17M(+9.5%)
Dec 2022
$144.47M
$26.68M(-51.7%)
$144.47M(-7.0%)
Sep 2022
-
$55.20M(+63.7%)
$155.32M(+19.0%)
DateAnnualQuarterlyTTM
Jun 2022
-
$33.73M(+16.9%)
$130.54M(+13.6%)
Mar 2022
-
$28.85M(-23.1%)
$114.88M(+16.6%)
Dec 2021
$98.56M(+3401.7%)
$37.53M(+23.4%)
$98.56M(+38.7%)
Sep 2021
-
$30.42M(+68.4%)
$71.07M(+43.6%)
Jun 2021
-
$18.07M(+44.2%)
$49.48M(+36.5%)
Mar 2021
-
$12.53M(+24.7%)
$36.25M(+1314.3%)
Dec 2020
-$2.98M(+96.0%)
$10.05M(+13.7%)
-$2.98M(+77.1%)
Sep 2020
-
$8.84M(+82.9%)
-$13.03M(+40.4%)
Jun 2020
-
$4.83M(+118.1%)
-$21.87M(+50.4%)
Mar 2020
-
-$26.70M(-53.5%)
-$44.10M(-57.5%)
Dec 2019
-$75.44M(-94.4%)
-
-
Jun 2019
-
-$17.40M(-64.2%)
-$28.00M(-164.2%)
Mar 2019
-
-$10.60M
-$10.60M
Dec 2018
-$38.80M
-
-

FAQ

  • What is Harmony Biosciences Holdings, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Harmony Biosciences Holdings, Inc.?
  • What is Harmony Biosciences Holdings, Inc. annual cash from operations year-on-year change?
  • What is Harmony Biosciences Holdings, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Harmony Biosciences Holdings, Inc.?
  • What is Harmony Biosciences Holdings, Inc. quarterly cash from operations year-on-year change?
  • What is Harmony Biosciences Holdings, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Harmony Biosciences Holdings, Inc.?
  • What is Harmony Biosciences Holdings, Inc. TTM cash from operations year-on-year change?

What is Harmony Biosciences Holdings, Inc. annual cash from operations?

The current annual cash from operations of HRMY is $219.82M

What is the all-time high annual cash from operations for Harmony Biosciences Holdings, Inc.?

Harmony Biosciences Holdings, Inc. all-time high annual cash from operations is $219.82M

What is Harmony Biosciences Holdings, Inc. annual cash from operations year-on-year change?

Over the past year, HRMY annual cash from operations has changed by +$434.00K (+0.20%)

What is Harmony Biosciences Holdings, Inc. quarterly cash from operations?

The current quarterly cash from operations of HRMY is $108.73M

What is the all-time high quarterly cash from operations for Harmony Biosciences Holdings, Inc.?

Harmony Biosciences Holdings, Inc. all-time high quarterly cash from operations is $108.73M

What is Harmony Biosciences Holdings, Inc. quarterly cash from operations year-on-year change?

Over the past year, HRMY quarterly cash from operations has changed by +$38.23M (+54.23%)

What is Harmony Biosciences Holdings, Inc. TTM cash from operations?

The current TTM cash from operations of HRMY is $297.61M

What is the all-time high TTM cash from operations for Harmony Biosciences Holdings, Inc.?

Harmony Biosciences Holdings, Inc. all-time high TTM cash from operations is $297.61M

What is Harmony Biosciences Holdings, Inc. TTM cash from operations year-on-year change?

Over the past year, HRMY TTM cash from operations has changed by +$76.69M (+34.71%)
On this page